Safety of sports for athletes with implantable cardioverter-defibrillators: Results of a prospective, multinational registry

Circulation

Volumn 127, Issue 20, 2013, Pages 2021-2030

  Lampert, Rachel ^a   Olshansky, Brian ^b   Heidbuchel, Hein ^c   Lawless, Christine ^d   Saarel, Elizabeth ^e   Ackerman, Michael ^f   Calkins, Hugh ^g   Estes, N A Mark ^h   Link, Mark S ^h   Maron, Barry J ⁱ   Marcus, Frank ^j   Scheinman, Melvin ^k   Wilkoff, Bruce L ^l   Zipes, Douglas P ^m   Berul, Charles I ⁿ   Cheng, Alan ^f   Law, Ian ^b   Loomis, Michele ^o   Barth, Cheryl ^a   Brandt, Cynthia ^a   Dziura, James ^a   Li, Fangyong ^a   Cannom, David ^p   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Sports Cardiology Consultants LLC   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f MAYO CLINIC   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^j UNIVERSITY OF ARIZONA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m INDIANA UNIVERSITY   (United States)

ⁿ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^o Michigan Heart   (United States)

^p GOOD SAMARITAN HOSPITAL   (United States)

more..

Author keywords

defibrillators; implantable; sports

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATHLETE; BASEBALL; BASKETBALL; CHILD; CONTROLLED STUDY; CYCLING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOTBALL; HEART VENTRICLE ARRHYTHMIA; HOCKEY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROCK CLIMBING; RUNNING; SAFETY; SCHOOL CHILD; SKIING; SOCCER; SPORT; SPORT INJURY;

DEFIBRILLATORS, IMPLANTABLE; SPORTS;

ADOLESCENT; ADULT; ATHLETES; ATHLETIC INJURIES; CHILD; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SPORTS; YOUNG ADULT;

EID: 84877961600     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000447     Document Type: Article

References (42)

1. Maron BJ, Zipes DP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1313-1375.
2. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biff A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology, Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:1422-1445.
3. Heidbüchel H, Corrado D, Biff A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defbrillators. Eur J Cardiovasc Prev Rehabil. 2006;13:676-686.
4. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defbrillators: a survey of Heart Rhythm Society members. J Cardiovasc Electrophysiol. 2006;17:11-15.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defbrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafey G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defbrillator Implantation Trial II Investigators. Prophylactic implantation of a defbrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
8. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality of life in the antiarrhythmics versus implantable defbrillators. Circulation. 2002;105:589-594.
9. McAllister DR, Motamedi AR, Hame SL, Shapiro MS, Dorey FJ. Quality of life assessment in elite collegiate athletes. Am J Sports Med. 2001;29:806-810.
10. Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE. Adolescents with implantable cardioverter defbrillators: a patient and parent perspective. Pacing Clin Electrophysiol. 2012;35:62-72.
11. Zeigler VL, Decker-Walters B. Determining psychosocial research priorities for adolescents with implantable cardioverter defbrillators using Delphi methodology. J Cardiovasc Nurs. 2010;25:398-404.
12. Barry MJ, Edgman-Levitan S. Shared decision making-pinnacle of patient-centered care. N Engl J Med. 2012;366:780-781.
13. Medbø JI, Sejersted OM. Plasma potassium changes with high intensity exercise. J Physiol. 1990;421:105-122.
14. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P. Effcacy of implantable cardioverter-defbrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-373.
15. Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L. Effcacy of implantable cardioverter-defbrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2003;26:1887-1896.
16. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA 3rd, Buja G, Thiene G. Implantable cardioverter-defbrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation. 2003;108:3084-3091.
17. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defbrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14:337-341.
18. Suddath WO, Deychak Y, Varghese PJ. Electrophysiologic basis by which epinephrine facilitates defbrillation after prolonged episodes of ventricular fbrillation. Ann Emerg Med. 2001;38:201-206.
19. Sousa J, Kou W, Calkins H, Rosenheck S, Kadish A, Morady F. Effect of epinephrine on the effcacy of the internal cardioverter-defbrillator. Am J Cardiol. 1992;69:509-512.
20. Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD. Sudden death in implantable cardioverter-defbrillator recipients: clinical context, arrhythmic events and device responses. J Am Coll Cardiol. 1999;33: 24-32.
21. Papaioannou GI, Kluger J. Ineffective ICD therapy due to excessive alcohol and exercise. Pacing Clin Electrophysiol. 2002;25:1144-1145.
22. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP; AVID Investigators, Antiarrhythmics Versus Implantable Defbrillators. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defbrillators (AVID) trial. Circulation. 2001;103:2066-2071.
23. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT; MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defbrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007;4:1395-1402.
24. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defbrilla-tor registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-1691.
25. van der Werf C, Zwinderman AH, Wilde AA. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace. 2012;14:175-183.
26. Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2011;8:864-871.
27. Lampert R, Soufer R, McPherson CA, Batsford WP, Tirado S, Earley C, Goldberg A, Shusterman V. Implantable cardioverter-defbrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol. 2007;18:512-517.
28. Qin H, Walcott GP, Killingsworth CR, Rollins DL, Smith WM, Ideker RE. Impact of myocardial ischemia and reperfusion on ventricular defbrilla-tion patterns, energy requirements, and detection of recovery. Circulation. 2002;105:2537-2542.
29. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and infuence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122:2359-2367.
30. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343:1355-1361.
31. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profles. JAMA. 1996;276:199-204.
32. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-1963.
33. Estes NA 3rd, Link MS, Cannom D, Naccarelli GV, Prystowsky EN, Maron BJ, Olshansky B; Expert Consensus Conference on Arrhythmias in the Athlete of the North American Society of Pacing and Electrophysiology. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol. 2001;12:1208-1219.
34. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation. 2002;106:1800-1805.
35. Maron BJ. The paradox of exercise. N Engl J Med. 2000;343:1409-1411.
36. Kramer DB, Maisel WH. Guidelines for managing pacemaker and implantable defbrillator advisories. In: Ellenbogen KA, ed. Clinical Cardiac Pacing, Defbrillation, and Resynchronization Therapy. Philadelphia, PA: Elsevier Saunders; 2011.
37. Heidbuchel H, Prior DL, La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med. 2012;46(suppl 1):i44-i50.
38. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B. Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-defcient mice. Circulation. 2006;114:1799-1806.
39. Heidbüchel H, Hoogsteen J, Fagard R, Vanhees L, Ector H, Willems R, Va n Lierde J. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratifcation. Eur Heart J. 2003;24:1473-1480.
40. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardio-verter-defbrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52:541-550.
41. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
42. Lara AA, Salberg L. Patient advocacy: what is its role? Pacing Clin Electrophysiol. 2009;32(suppl 2):S83-S85.